CP
CPCI.EGX Cairo Pharmaceuticals
613.48 EGP
Close of Oct 29, 2026
246.54
613.48
- Market cap
- -
- P/E
- -
- P/B
- -
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Is CPCI.EGX undervalued?
Graham numberThe Graham number of Cairo Pharmaceuticals cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Cairo Pharmaceuticals fundamental analysis
No fundamental analysis for Cairo Pharmaceuticals yet.
Cairo Pharmaceuticals stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
Financial statements of Cairo Pharmaceuticals are not available yet.
Cairo Pharmaceuticals dividends
Cairo Pharmaceuticals has not paid dividends in the last 1 fiscal years.
Who owns Cairo Pharmaceuticals
Ownership data of Cairo Pharmaceuticals is not available yet.
Cairo Pharmaceuticals company profile
- Company name
- Cairo Pharmaceuticals
- Ticker
- CPCI.EGX
- ISIN
- EGS38391C016
- Exchange
- Egyptian Exchange
- Sector
- -
- Industry
- -
- Address
- Website
- -